Search Results - "TOLOSA, E"

Antenatal Betamethasone for Women at Risk for Late Preterm Delivery by Gyamfi-Bannerman, Cynthia, Thom, Elizabeth A, Blackwell, Sean C, Tita, Alan T.N, Reddy, Uma M, Saade, George R, Rouse, Dwight J, McKenna, David S, Clark, Erin A.S, Thorp, John M, Chien, Edward K, Peaceman, Alan M, Gibbs, Ronald S, Swamy, Geeta K, Norton, Mary E, Casey, Brian M, Caritis, Steve N, Tolosa, Jorge E, Sorokin, Yoram, VanDorsten, J. Peter, Jain, Lucky

“…In this multicenter, randomized trial involving women at high risk for late preterm delivery, administration of betamethasone significantly reduced the rate of…”
Get full text

The role of DAT-SPECT in movement disorders by Kägi, G, Bhatia, K P, Tolosa, E

“…Dopamine transporter (DAT) imaging is a sensitive method to detect presynaptic dopamine neuronal dysfunction, which is a hallmark of neurodegenerative…”
Get full text

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy by Obeso, J.A., Stamelou, M., Goetz, C.G., Poewe, W., Lang, A.E., Weintraub, D., Burn, D., Halliday, G.M., Bezard, E., Przedborski, S., Lehericy, S., Brooks, D.J., Rothwell, J.C., Hallett, M., DeLong, M.R., Marras, C., Tanner, C.M., Ross, G.W., Langston, J.W., Klein, C., Bonifati, V., Jankovic, J., Lozano, A.M., Deuschl, G., Bergman, H., Tolosa, E., Rodriguez‐Violante, M., Fahn, S., Postuma, R.B., Berg, D., Marek, K., Standaert, D.G., Surmeier, D.J., Olanow, C.W., Kordower, J.H., Calabresi, P., Schapira, A.H.V., Stoessl, A.J.

“…ABSTRACT This article reviews and summarizes 200 years of Parkinson's disease. It comprises a relevant history of Dr. James Parkinson's himself and what he…”
Get full text

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease by Ferreira, J. J., Katzenschlager, R., Bloem, B. R., Bonuccelli, U., Burn, D., Deuschl, G., Dietrichs, E., Fabbrini, G., Friedman, A., Kanovsky, P., Kostic, V., Nieuwboer, A., Odin, P., Poewe, W., Rascol, O., Sampaio, C., Schüpbach, M., Tolosa, E., Trenkwalder, C., Schapira, A., Berardelli, A., Oertel, W. H.

“…© 2012 The Author(s) European Journal of Neurology © 2012 EFNS Objective: To summarize the 2010 EFNS/MDS-ES evidence-based treatment recommendations for the…”
Get full text

A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes by Landon, Mark B, Spong, Catherine Y, Thom, Elizabeth, Carpenter, Marshall W, Ramin, Susan M, Casey, Brian, Wapner, Ronald J, Varner, Michael W, Rouse, Dwight J, Thorp, John M, Sciscione, Anthony, Catalano, Patrick, Harper, Margaret, Saade, George, Lain, Kristine Y, Sorokin, Yoram, Peaceman, Alan M, Tolosa, Jorge E, Anderson, Garland B

“…In this randomized trial of treatment versus no treatment for mild gestational diabetes mellitus, rates of the primary outcome (a composite of stillbirth or…”
Get full text

Neonatal Morbidity of Small- and Large-for-Gestational-Age Neonates Born at Term in Uncomplicated Pregnancies by Chauhan, Suneet P., Rice, Madeline Murguia, Grobman, William A., Bailit, Jennifer, Reddy, Uma M., Wapner, Ronald J., Varner, Michael W., Thorp, John M., Leveno, Kenneth J., Caritis, Steve N., Prasad, Mona, Tita, Alan T. N., Saade, George, Sorokin, Yoram, Rouse, Dwight J., Tolosa, Jorge E.

“…OBJECTIVE:To compare morbidity among small-for-gestational-age (SGA; birth weight less than the 10th percentile for gestational age),…”
Get full text

Association Between Gestational Weight Gain and Perinatal Outcomes by Kominiarek, Michelle A., Saade, George, Mele, Lisa, Bailit, Jennifer, Reddy, Uma M., Wapner, Ronald J., Varner, Michael W., Thorp, John M., Caritis, Steve N., Prasad, Mona, Tita, Alan T.N., Sorokin, Yoram, Rouse, Dwight J., Blackwell, Sean C., Tolosa, Jorge E.

“…OBJECTIVE:To evaluate the association between gestational weight gain and maternal and neonatal outcomes in a large, geographically diverse cohort…”
Get full text

Inadequate weight gain in overweight and obese pregnant women: what is the effect on fetal growth? by Catalano, Patrick M., MD, Mele, Lisa, ScM, Landon, Mark B., MD, Ramin, Susan M., MD, Reddy, Uma M., MD, MPH, Casey, Brian, MD, Wapner, Ronald J., MD, Varner, Michael W., MD, Rouse, Dwight J., MD, Thorp, John M., MD, Saade, George, MD, Sorokin, Yoram, MD, Peaceman, Alan M., MD, Tolosa, Jorge E., MD, MSCE

“…Objective We sought to evaluate inadequate gestational weight gain and fetal growth among overweight and obese women. Study Design We conducted an analysis of…”
Get full text

Structural correlates of facial emotion recognition deficits in Parkinson's disease patients by Baggio, H.C., Segura, B., Ibarretxe-Bilbao, N., Valldeoriola, F., Marti, M.J., Compta, Y., Tolosa, E., Junqué, C.

“…The ability to recognize facial emotion expressions, especially negative ones, is described to be impaired in Parkinson's disease (PD) patients. Previous…”
Get full text

Cholinergic denervation in patients with idiopathic rapid eye movement sleep behaviour disorder by Gersel Stokholm, M., Iranzo, A., Østergaard, K., Serradell, M., Otto, M., Bacher Svendsen, K., Garrido, A., Vilas, D., Fedorova, T.D., Santamaria, J., Møller, A., Gaig, C., Hiraoka, K., Brooks, D.J., Okamura, N., Borghammer, P., Tolosa, E., Pavese, N.

“…Background and purpose Cholinergic dysfunction appears to play a role in the cognitive impairment observed in Parkinson’s disease and dementia with Lewy…”
Get full text

The premotor phase of Parkinson's disease by Tolosa, E, Compta, Y, Gaig, C

“…Abstract There is growing evidence that a variety of symptoms can precede the classical motor features of Parkinson's disease (PD). The period when these…”
Get full text

Terminal Complement Activation in Preeclampsia by Burwick, Richard M., Velásquez, Jesús A., Valencia, Catalina M., Gutiérrez-Marín, Jorge, Edna-Estrada, Francisco, Silva, Jaime L., Trujillo-Otálvaro, Juliana, Vargas-Rodríguez, Johanna, Bernal, Yamile, Quintero, Alvaro, Rincón, Mónica, Tolosa, Jorge E.

“…OBJECTIVE:To evaluate whether C5b-9 concentrations in blood and urine are increased in preeclampsia with severe features. METHODS:The Complement and…”
Get full text

Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial by Rascol, O, Brooks, DJ, Melamed, E, Oertel, W, Poewe, W, Stocchi, F, Tolosa, E

“…Rasagiline mesylate is a novel drug for Parkinson's disease with selective, irreversible monoamine oxidase B (MAO-B) inhibitor activity, and is effective as…”
Get full text

Neurophysiologic study of central pain in patients with Parkinson disease by SCHESTATSKY, P, KUMRU, H, VALLS-SOLE, J, VALLDEORIOLA, F, MARTI, M. J, TOLOSA, E, CHAVES, M. L

“…Patients with Parkinson disease (PD) may present with various types of pain. In some instances, no cause can be identified and pain is considered a primary…”
Get full text

Increased frequency of TIGIT+CD73-CD8+ T cells with a TOX+ TCF-1low profile in patients with newly diagnosed and relapsed AML by Brauneck, F., Haag, F, Woost, R., Wildner, N., Tolosa, E., Rissiek, A., Vohwinkel, G., Wellbrock, J., Bokemeyer, C., Schulze zur Wiesch, J., Ackermann, C., Fiedler, W.

“…The inhibitory receptor TIGIT, as well as theectonucleotidases CD39 and CD73 constitute potential exhaustion markers for T cells. Detailed analysis of these…”
Get full text

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder by Boeve, B.F, Silber, M.H, Ferman, T.J, Lin, S.C, Benarroch, E.E, Schmeichel, A.M, Ahlskog, J.E, Caselli, R.J, Jacobson, S, Sabbagh, M, Adler, C, Woodruff, B, Beach, T.G, Iranzo, A, Gelpi, E, Santamaria, J, Tolosa, E, Singer, C, Mash, D.C, Luca, C, Arnulf, I, Duyckaerts, C, Schenck, C.H, Mahowald, M.W, Dauvilliers, Y, Graff-Radford, N.R, Wszolek, Z.K, Parisi, J.E, Dugger, B, Murray, M.E, Dickson, D.W

“…Abstract Objective To determine the pathologic substrates in patients with rapid eye movement (REM) sleep behavior disorder (RBD) with or without a coexisting…”
Get full text

Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's disease by Brockmann, K., Schulte, C., Schneiderhan‐Marra, N., Apel, A., Pont‐Sunyer, C., Vilas, D., Ruiz‐Martinez, J., Langkamp, M., Corvol, J.‐C., Cormier, F., Knorpp, T., Joos, T. O., Bernard, A., Gasser, T., Marras, C., Schüle, B., Aasly, J. O., Foroud, T., Marti‐Masso, J. F., Brice, A., Tolosa, E., Berg, D., Maetzler, W.

“…Background and purpose The presentation of Parkinson's disease patients with mutations in the LRRK2 gene (PDLRRK2) is highly variable, suggesting a strong…”
Get full text

1.14.4 IMPULSE CONTROL DISORDERS by Tolosa, E

Get full text

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial by Antonini, A., Bauer, L., Dohin, E., Oertel, W. H., Rascol, O., Reichmann, H., Schmid, M., Singh, P., Tolosa, E., Chaudhuri, K. Ray

“…Background and purpose Non‐motor symptoms (NMS) of Parkinson's disease (PD) have a major impact on health‐related quality of life. This is the first randomized…”
Get full text

Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's disease by Tolosa, E., Stern, M. B.

“…Background:  Rasagiline, an MAO‐B inhibitor, is indicated for the treatment of Parkinson’s disease (PD). In this post hoc analysis, the efficacy, safety and…”
Get full text